Detalhe da pesquisa
1.
Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype.
Cytotherapy
; 21(6): 593-602, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975603
2.
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma.
Cancer Immunol Immunother
; 67(9): 1461-1472, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30014244
3.
Logic-gated approaches to extend the utility of chimeric antigen receptor T-cell technology.
Biochem Soc Trans
; 46(2): 391-401, 2018 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29540509
4.
GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade.
Mol Ther
; 24(6): 1135-1149, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27019998
5.
DNA vaccines encoding membrane-bound or secreted forms of heat shock protein 70 exhibit improved potency.
Eur J Immunol
; 44(7): 1992-2002, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723366
6.
Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
Cytotherapy
; 17(4): 487-95, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573334
7.
Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response.
Immunol Cell Biol
; 92(4): 359-67, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24323081
8.
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
J Immunother Cancer
; 12(5)2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754916
9.
A Poisson distribution-based general model of cancer rates and a cancer risk-dependent theory of aging.
Aging (Albany NY)
; 15(17): 8537-8551, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659107
10.
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma.
Front Immunol
; 14: 1261257, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928547
11.
Genome-wide identification of human FOXP3 target genes in natural regulatory T cells.
J Immunol
; 185(2): 1071-81, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20554955
12.
Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma.
Front Immunol
; 13: 850226, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35464424
13.
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167468
14.
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.
Cancer Res Commun
; 2(7): 706-724, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923279
15.
Erratum: Clinical chimeric antigen receptor T-cell therapy: a new and promising treatment modality for glioblastoma.
Clin Transl Immunology
; 10(8): e1331, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34401149
16.
Effects of Chemotherapy Agents on Circulating Leukocyte Populations: Potential Implications for the Success of CAR-T Cell Therapies.
Cancers (Basel)
; 13(9)2021 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34066414
17.
The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy.
Cells
; 10(3)2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803414
18.
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Mol Imaging Biol
; 23(6): 914-928, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231102
19.
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy.
Clin Transl Immunology
; 9(10): e1191, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33082953
20.
Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma.
Clin Transl Immunology
; 8(5): e1050, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31139410